Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A 6 Month, Open Label, Ambulatory Blood Pressure Monitoring (ABPM) Extension Study

Next Previous
X
Search
Trial Profile

A 6 Month, Open Label, Ambulatory Blood Pressure Monitoring (ABPM) Extension Study

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 03 Aug 2024

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Testosterone undecanoate (Primary)
  • Indications Hypogonadism
  • Focus Registrational; Therapeutic Use
  • Acronyms MRS-TU-2019EXT
  • Sponsors Marius Pharmaceuticals

    • Most Recent Events

    • 30 Jul 2024 According to a Marius Pharmaceuticals media release, the company announce the submission of its New Drug Submission (NDS) for KYZATREX (testosterone undecanoate) CIII capsules to Health Canada for approval with an anticipated approval date in Q2 of 2025.
    • 11 Apr 2024 According to a Marius Pharmaceuticals media release, data from the study were presented in Therapeutic Advances in Urology,
    • 11 Apr 2024 Results (n=139) presented in the Marius Pharmaceuticals Media Release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top